One of the major challenges for bone tissue engineering is the production of a suitable scaffold material. In this review the currently available composite material options are considered and the methods of production and assessing the scaffolds are also discussed. The production routes range from the use of porogens to produce the porosity through to controlled deposition methods. The testing regimes include mechanical testing of the produced materials through to in vivo testing of the scaffolds. While the ideal scaffold material has not yet been produced, progress is being made.
INTRODUCTION
The requirements for scaffold materials for use in bone tissue engineering are easily defined; however, our ability to produce such materials is limited. The scaffold needs to contain both macropores, 300-400 mm across, to allow osteons or bone spicules to grow into the scaffold [1] and micropores to encourage nutrient supply and the removal of waste products [2, 3] . The material needs to be bone bioactive, that is it encourages bone ingrowth, and to degrade at a rate that allows the newly formed tissue to gradually replace the scaffold, both as a mechanical structure and in terms of space occupied. Finally, and this is where most current materials fail, the material needs mechanical properties that allow the device to be implanted without failing. This last requirement allows a patient to use the implanted area without mechanical protection, such as a cast, but still allows sufficient loading of the newly formed tissue to mechanically stimulate the osteoblasts. As yet no one has reported a material that fulfils all these requirements.
One group of materials that does attempt to fulfil many of these requirements are composites of degradable polymers reinforced with ceramics, glass-ceramics, or bioglasses. If the polymer is biodegradable and the ceramic, glass-ceramic, or bioglass phase is degradable or metabolized by the body then the degradation requirement is fulfilled. The use of ceramics or glassceramics can both stiffen and strengthen a low modulus and low strength polymer and increase the bioactivity of the composite [4] . A range of techniques can be used to develop a porous structure, including porogens that are processed into the material and then develop the required porosity either by generating gas bubbles or by being dissolved out and leaving spaces. Other methods of generating porosity include depositing the material with gaps between individual material fibres such as electrospinning and fused laser deposition.
This review will consider only composite scaffolds, as the use of composites allows the combination of bioactive ceramics or glasses (which are stiff and bioactive, but normally are too brittle for loadbearing applications) with polymers (which usually are ductile but do not have sufficient stiffness or biological activity) for mechanically successful bone implantation. These composite scaffolds can be produced by a variety of methods: including manufacturing a composite material in a porous form, taking a brittle ceramic scaffold and toughening it by coating with a polymer, or taking a tough polymeric scaffold and coating it with a bioactive layer, using a technique such as soaking in supersaturated simulated body fluid (SBF) or calcium and phosphate containing solutions. The most commonly used SBF is SBF-K9 developed by Kokubo et al. [5] in order to test the relative bone bioactivity of ceramics and glass-ceramics. SBF-K9 has very similar ionic concentrations to blood plasma, but no protein content, the rate at which it deposits on a bone bioactive material is usually considered to be indicative of the rate of incorporation in the body in vivo and deposition does not occur on non-bone bioactive materials [6] . If, however, the SBF strength is increased then a hydrated carbonate apatite (HCA) layer can be deposited on a bioinert surface rendering it bioactive [7] . The artificial polymers used include polylactic acid (PLA), polyglycolic acid (PGA), polycaprolactone (PCL) and polyhydroxybuterate (PHB) and several of their co-polymers such as PLLA and PLDLA depending on the amounts of L and D stereoisomers of PLA and PLGA a co-polymer of PLA and PGA and polymer blends. From natural sources there are two major polymers, collagen, the main connective tissue of the body, and chitosan, which is purified from the shells of prawns and other shellfish. Collagen for use as a biomaterial is usually purified from bovine tendon, although bone and dentine are other potential sources [8] . Chitosan is biodegradable and its mechanical properties can be altered by its degree of acetylation, furthermore it can absorb and release various cytokines and other bioactive molecules, thus changing its biological response to an implanted material [9, 10] . The fillers used include tricalcium phosphate (Ca 3 (PO 4 ) 2 -TCP), a degradable calcium phosphate related to hydroxyapatite (Ca 10 (PO 4 ) 6 (OH) 2 -HA), which in turn is the stoichiometric version of bone mineral, bioglasses of various types such as BioglassH 45S5 and other glass-ceramics including A-W glass ceramic. When considering ceramic-polymer composite formulation the factor of typically three difference in the density of the ceramic and the polymer phases leads to major differences in the filler content when defined as weight percentage or volume percentage. This review will consider the methods of producing the required porosity and the materials used. The testing regimes from in vitro bioactivity, to in vitro cell culture, and finally in vivo testing will be reviewed.
POROGEN-MANUFACTURED SCAFFOLDS
Porogens, or substances that produce porosity, are available in three basic types: those that dissolve, those that melt, and those that produce gas bubbles. The two most commonly used soluble porogens are sugar and salt both of which are available in a variety of sizes that enables the creation of a suitable range of pore sizes and both are highly water soluble. Furthermore, the products are not cytotoxic, except in very high doses, so any porogen remaining after dissolution which subsequently leaches out in vivo, will not generate a cytotoxic response. The second group are waxes which are removed by melting, these have been used less often, probably due to concerns over any wax remaining in a closed cell. Some carbon dioxide (CO 2 )-producing chemical reactions based porous scaffolds have been produced. Porogens have been used to manufacture PLA, PGA, and PHB-based scaffolds.
PLA scaffolds produced using porogens
Porous PLDLA reinforced with 20 or 50 wt% calcium phosphate glass scaffolds have been produced by a solution casting technique that used sodium chloride salt particles to produce porosity [11, 12] . After dissolving the PLDLA in chloroform the P 2 O 5 -CaO-Na 2 O-TiO 2 -based glass and salt were added and the chloroform was allowed to evaporate resulting in the salt dissolving out of the solution. The authors reported increased protein absorption with increasing glass content. They subsequently cultured cells from the MG63 osteoblast cell line on the scaffolds in both static and dynamic (perfusion) environments [13] . They found increases in cell proliferation and differentiation on the glass-containing composite compared with the plain PLDLA. They found that the perfusion regime increased the cell seeding efficiency and produced a more even cell distribution. For 95 per cent porous scaffolds they were able to obtain scaffold stiffness values of up to 217 kPa by optimizing the size of the glass and salt particles. However, they do comment that at this level of porosity the glass filler particles do not act so as to stiffen or strengthen the polymer but rather act as defects due to the lack of bonding between the polymer and the glass particles. The smooth surfaces of glass particles often lead to a low strength interface between the filler and matrix and thus poor mechanical properties [14] . While chemical coupling agents have been used in non-degradable composites [15] their use in degradable composites such as tissue scaffolds requires consideration of the toxicity of their degradation products.
There are reports in the literature on the use of the natural structure of coral to provide the required macro and micro pore size and shape for bone scaffold materials. Kusmanto et al. [16] used a naturally porous red coralline alga, Phymatolithon calcareum, with a mean pore size of 7 mm to produce the required macropores. Pyrolysis was used to convert the coral to CaO and then to CaCO 3 and finally hydrothermal conversion was used to transform the material to microporous HA which was mixed with PCL to produce the composite. Salt particles were used as the porogen to produce macropores. Scanning electron microscopy (SEM) investigations showed that the HA particles retained the microporosity of the alga precursor and that the macroporosity depended on the size of the salt particles. For a given porosity level the stiffness and strength were higher when larger salt particles were used, that is the pore size was increased. Cell culture experiments showed the materials to be biocompatible; with cells from the MG63 osteoblast-like cell line being able to interact with the micropores in the HA phase ( Fig. 1 ).
PLA-glycolic acid scaffolds produced using porogens
Kim et al. [17] compared composite scaffolds of PLA-glycolic acid (PLGA) reinforced with HA made using gas foaming and porogen leaching with those made using the more conventional solvent casting and porogen leaching approach. The solvent cast samples had open cells 100-200 mm in diameter whereas the gas foamed samples possessed both open cells of similar size to those in the other sample that were the result of the dissolution of the salt particles and closed cells 10-45 mm in diameter, which thus increased the average porosity from 85 to 91 per cent. However, the gas foam samples had twice the compressive modulus and 13 times the tensile modulus to the solution cast scaffolds. Cell culture studies, using rat calveria osteoblasts, showed that the addition of the HA increased the cell number and calcification compared to the unfilled solvent cast PLGA and a higher activity was found on the gas foam samples. When implanted subcutaneously in nude mice a similar trend was seen to the in vitro cell culture studies. Guarino and Ambrosio [18] used filament winding to produce scaffolds of drawn PLA fibres in a matrix of PCL reinforced with up to 26 vol% a-TCP using salt particles to produce porosity. The PLA fibres were drawn through a solution of PCL in dimethylacetamide with a-TCP and salt particles 300-500 mm in diameter suspended in the solution. The coated PLA fibres were then filament wound to produce the material and soaked in water for 24 h to leach out the salt particles. This production method lead to tubular specimens of 3 mm internal diameter, 7 mm external diameter with 80 per cent porosity consisting of macropores 100-400 mm in diameter connected by micropores. The addition of the a-TCP increased the modulus from 0.49 ¡ 0.04 to 2.21 ¡ 0.24 MPa in the initial linear region of the stress-strain curve and the material behaved in a foam-like manner in that it gradually compacted as the load increased.
Other porogen-produced scaffolds
Li et al. [19] and Li and Chang [20] manufactured scaffolds of poly hydroxybutyratevalerate (PHBV) reinforced with up to 20 wt% of a bioglass or wollastonite glass and used salt leaching to generate the requisite porosity. For porosities of 77 to 80 per cent the addition of the bioglass increased the yield strength from 0.16 ¡ 0.03 to 0.41 ¡ 0.09 MPa. Pore sizes were between 30 and 300 mm. Soaking in SBF showed the 20 wt% bioglass composite to be potentially bioactive, although the water contact angle decreased with increasing bioglass content. The pH of the solution remained constant for the first 8 days when there was no reinforcing phase and then decreased with a major drop seen after 8 weeks, whereas with the filled composites the pH of the solution initially increased slightly and then remained constant. The addition of the filler particles also reduced the degradation as measured by the molecular weight of the polymer phase.
Oliveira et al. [21] used co-precipitation to produce composites of carboxymethylchitosan reinforced with 24 vol% HA. Wax spheres 50-450 mm in diameter were incorporated to produce the required porosity and the wax was subsequently removed by soaking the scaffolds in tetrahydrofuran which was then removed by freeze drying. Open celled pores 20-500 mm across were produced with specimen porosity of nearly 60 per cent and the scaffolds were shown to be bone bioactive by being coated with an apatitic layer after soaking in SBF. The compressive stiffness and strength were 57.3 and 51.0 MPa, respectively.
POROUS MANUFACTURE
The two most commonly used methods of direct porous manufacture are supercritical processing and freeze drying directly from a suspension, with newer techniques such as fused deposition and electrostatic spraying becoming increasingly popular.
Fused deposition has been used to manufacture scaffolds of PCL reinforced with 20% TCP and these scaffolds were subsequently subjected to a series of studies [22] [23] [24] . The scaffolds were laid down with a 0u/60u/120u pattern that produced hexagonal channels 600 mm across throughout the scaffolds (Fig. 2) .
The degradation of the scaffolds was investigated and it was shown that they could survive for at least 28 days with changes in the pH of the solution only appearing after 20 days. These scaffolds were also shown to be capable of releasing BMP-2 and thus could be used to upregulate osteoblasts during the first few post-operative days.
Chen and Boccaccini [25] developed scaffolds of Bioglass 45S5 reinforced with PHB by using a slurry of Bioglass 45S5 to coat polyurethane (PU) foams with either 45 or 60 pores per inch (25 mm). After sintering the structure consisted of rods of Bioglass and these scaffolds were then immersed in a solution of PHB in chloroform. After drying the presence of the PHB coating reduced the surface tension. They showed the bioactivity of the scaffolds by the development of an apatitic coating after soaking in SBF for up to 28 days. Finally, cells from the HOS-TE85 osteoblast cell line were grown on the scaffolds and showed similar responses to coated and uncoated specimens although the cells did appear to attach better to the PHB-coated specimens [26] .
Liao and Cui [27] Liao et al. [28] , and Liao et al. [29] manufactured a composite of nanoHA in type-I collagen, they then used this material to reinforce poly-L-lactide (PLLA) with the porosity generated by a freeze drying process. The pores were 100-300 mm across and the compressive strength was between 13 and 1.9 MPa for 8 to 12% PLLA content, with the compressive modulus being between 20 and 45 MPa. Both in vitro and in vivo testing showed the material to be biocompatible and bioactive. One method of increasing the mechanical properties is to add reinforcement in the form of fibres or to cross-link the polymeric phase, thus Li et al. [30] took this material and added chitosan fibres which in some cases they cross-linked. Increasing the chitosan fibre content from 10 to 50 vol% lead to a reduction in porosity from 91 to 83 per cent and the mean pore size from 190 ¡ 5 to 140 ¡ 5 mm. Adding chitosan fibres without any cross-linking increased the modulus from 1.71 to 4.1 MPa at 22 vol% content, but when the fibres were cross-linked the modulus reached 8.36 MPa. Adding the chitosan fibres increased the hydrophilicity of the PLLA/nanoHA/ collagen composite and thus attachment of bonemarrow-derived mesenchymal cells with neglible mechanical effects produced by the cross-linking.
Catledge et al. [31] used electrospinning to produce scaffolds of PCL, collagen, and PCL-collagen all reinforced with 20 wt% nanoHA. All three composites produced porous scaffolds and nanoindentation after compaction showed that the highest Young's modulus for the fibres was found for the collagen-nanoHA scaffold followed by the PCLcollagen-nanoHA. Heo et al. [32] and Heo et al. [33] dissolved nanosized HA into a solution of PLA and then used a rapid prototyping system to create scaffolds built from 300 mm diameter rods of the composite with the rods being separated by about 500 mm. Each layer was deposited at right angles to the underlying layer in a layer manufacturing process ( Fig. 3 ). Micron-sized HA-based scaffolds were used as controls and the porosity of both scaffolds was 72-73 per cent. Compression testing showed more effective reinforcement by the nanoHA particles (with a modulus of 3.2 ¡ 0.1 MPa) compared with the macroHA-reinforced composite (with a modulus of 1.3 ¡ 0.1 MPa). Contact angle measurements showed the nanoHAreinforced scaffolds to have faster water absorption which correlated with higher MG63 osteoblast cell line attachment from 4 h to 7 days. SEM investigations showed that the scaffolds produced with the nanoHA were much smoother allowing the cells to spread more extensively. Mesenchymal stem cells were also cultured on both these scaffolds and also proliferated and differentiated more on the nanoHAreinforced scaffolds. The nanoHA-reinforced scaffolds were then implanted into critical-sized defects in rabbit tibiae with nanoHA-reinforced scaffolds produced by a more conventional porogen-based technique, but with similar porosity, as controls.
There was higher, and more organized, osteoid deposition in the layer-manufactured scaffolds than those produced using the porogen technique. Hong et al. [34] used a similar technique to produce 50 wt% HA in PCL scaffolds and showed similar cell viability for rat-bone-marrow stromal cells, but with increased cell differentiation for the HA-PCL scaffolds than the non-reinforced PCL scaffolds.
Costa et al. [35] and Mansur and Costa [36] foamed polyvinyl alcohol (PVA) reinforced with 20 to 40 wt% of 58%SiO 2 -33%CaO-9%P 2 O 5 glass to produce porous scaffolds. After morphological, chemical, and mechanical characterizations the scaffolds were cultured with cells from the VERO line. At 30 wt% glass the effect of increasing the molecular weight of the PVA from 9000-10 000 to 13 000-23 000 g/mol was to increase the stiffness of the scaffold from 2.6 to 5.9 MPa, although there was minimal change in the strength. The authors note that the glass alone did not have sufficient mechanical properties to be handled, let alone tested. The cell culture studies showed good cell viability on the composite scaffolds.
Duarte et al. [37] used supercritical processing to produce porous scaffolds of starch-polylactic acid blend reinforced with 0, 10, or 15 wt% Bioglass 45S5. Dynamic mechanical analysis (DMA) was used to measure the compressive mechanical properties of the scaffolds and showed that the addition of the Bioglass increased the dynamic stiffness. Soaking in SBF showed the composites to have higher bone bioactivity than the non-filled polymer.
Liu et al. [38] and Liu et al. [39] used PLLA, PLDLA, and PGA all reinforced with 30 or 50 wt% TCP and a combination of low-temperature deposition (to produce macropores or channels through the materials) and freeze drying (to produce micropores) to create their samples. In a series of purely mechanical tests they optimized the production route. A 30 wt% TCP content gave a stronger material than 50 wt% TCP for each polymer and using PLLA as the matrix material lead to the highest mechanical properties at each filler level. They subsequently used a multi-nozzle system to co-deposit PLGA reinforced with 25 wt% TCP with collagen or chitosan or gelatin to produce biphasic scaffolds. One such scaffold included blood vessel scaffolds laid down through the bone scaffold.
Zhang and Zhang [9] used both b-TCP and a CaO-P 2 O 5 -TiO 2 -Na 2 O glass to reinforce chitosan and then freeze drying to generate porosity. Porosities between 75 and 90 per cent were achieved with compressive moduli between 1 and 3 MPa and strengths between 0.1 and 0.3 MPa. Soaking in SBF showed the materials to be bioactive. 
CERAMIC DEPOSITION ONTO POLYMERS
A bioceramic layer can be deposited onto a scaffold by soaking the polymeric scaffold in above-physiological-strength SBF. If the strength of the SBF solution is increased then the rate of deposition is substantially increased and deposition will occur on many non-bioactive materials including porous polymer scaffolds rendering them bioactive. In addition pretreatment with acid or alkaline solutions may generate apatite nuclei and thus allow the deposition on non-bioactive surfaces [6] . Al-Munajjed and O'Brien [40] used freeze drying from a suspension of collagen to produce a 90 per cent porous collagen scaffold which was alternately immersed in 0.1-1.0 M strength solutions of calcium chloride (CaCl 2 ) and ammonium sodium hydrogen phosphate (NaNH 4 HPO 4 ) to produce a calcium phosphate coating. They optimized the solution concentrations, soak times, and number of immersions and their order and increased the modulus from 0.27 to 10.3 kPa. The coating was shown to be mainly HA with some small amounts of other calcium phosphates. Al-Munajjed et al. [41] extended this approach and soaked collagen scaffolds for 4 days in SBF at fivetimes physiological strength (5SBF) to coat a 99.5 per cent porous collagen scaffold. The coating process increased the strength from 0.23 to 0.9 kPa and mouse MC3T3-E1 pre-osteoblast cells grown on the scaffolds showed minimal differences in their responses to the coated or non-coated scaffolds.
Douglas et al. [42] produced PLGA scaffolds by a salt leaching process and then soaked the scaffolds in a 3SBF solution to produce an apatite coating. No mechanical tests were performed, but cell culture with human osteoblasts showed the scaffolds to be biocompatible.
Jie and Li [43] precipitated nanoHA into PA66 polyamide (nylon) by dissolving calcium nitrate in the polyamide using an organic solvent and then reacting this solution with sodium phosphate. After cleaning the composite scaffold was produced using an injection foaming method. The nanoHA content was between 39 and 64 wt% and as the nanoHA content increased the elastic modulus increased from 3.6 ¡ 0.3 to 5.6 ¡ 0.3 GPa and the compressive strength from 93 ¡ 7 to 117 ¡ 4 MPa. X-ray diffraction (XRD), transmission electron microscopy, and infrared spectroscopy showed the mineral phase to be nanoparticles of HA. Increasing the nanoHA content, in addition to increasing the porosity from 71 to 80 per cent, also changed the closed-cell and open-cell macropore content from 9 and 91 per cent, respectively to 19 and 81 per cent, respectively, although it should be noted that the closed cells were also interconnected by micropores. In subsequent studies they used thermally induced phase separation to produce the porosity and were able to obtain anisotropic pores, leading to up to a factor of two difference in the longitudinal and transverse compressive moduli and strengths and a maximum strength of 550 MPa [44] . However, it seems unlikely that this material will be degradable.
Mavis et al. [45] used electrospinning to produce mats of nano-sized PCL fibres that were subsequently soaked in four of their own recipe 10SBF solutions for between 2 and 15 h ( Figure 5 ). The deposited particles were found to have Ca:P ratios between 1.3 and 1.5 and were therefore thought to be TCP or other various low calcium content CaP phases which are expected to quickly degrade on implantation. Cultures made using the MC3T3-E1 cell line showed that the materials were biocompatible and indeed bioactive with the cell activity on the coated scaffolds being higher than those of uncoated control scaffolds.
Oyane et al. [46] and Oyane et al. [47] took plain PCL laid down in a 0u/60u/120u pattern to give a hexagonal scaffold (similar to [22] [23] [24] ), then used either sodium hydroxide (NaOH) to produce carboxylate groups on the surface followed by alternate CaCl 2 and K 2 HPO 4 aqueous solution treatments or an oxygen plasma treatment followed by soaking in the same calcium and phosphate salts dissolved in either water or an ethanol:water mix. Their dipping times were much shorter than the other studies at 10 s per dip and only three dips per solution. The NaOH pretreatment was found to need 2 or 5 M strength solutions to pre-condition the surface to allow formation of an apatite layer after 24 h in SBF. The oxygen plasma treatment decreased the contact angle, as did the use of ethanol in the solution and use of a joint oxygen plasma and 0.2 M strength ethanol solution treatment modified the surface such that after 24 h in SBF the surface was totally covered in apatite.
A different approach was taken by Davis et al. [48] in that they used a modified SBF to deposit an apatite layer on PLGA microspheres that were subsequently used to create scaffolds with either the generation of CO 2 gas or salt particles being used to produce porosity. They used human mesenchymal stem cells to assess the biocompatibility. The scaffolds were found to be osteoconductive, that is to say that bone would grow over the surface if the material was implanted in contact with bone.
PHB with 8 mol% polyhydroxyvalerate was manufactured into porous scaffolds using salt as a porogen by Huang et al. [49] . After the salt was leached out and the samples dried, they were soaked in calcium hydroxide solution for a week, to produce apatite nucleation sites, and then seven cycles of soaking in 100 mM CaCl 2 in Tris buffer for 24 h followed by 100 mM Na 2 HPO 4 in Tris buffer for 24 h, with the samples washed between each solution. SEM and XRD showed that nanoparticles of apatite had been deposited in a continuous layer over the surface.
A similar pair of solutions was used by Matsusaki et al. [50] who produced a scaffold of extracellular matrix including mesenchymal stem cells and then soaked this alternately in CaCl 2 in a 50 mM Trishydrochloric acid (HCl) buffer and in Na 2 HPO 4 in a 50 mM Tris-HCl buffer for 10 s each with a 10s wash in a plain 50 mM Tris-HCl buffer between each active solution. The strengths of each of the CaCl 2 and Na 2 HPO 4 solutions were varied between 10 and 200 mM and either ten or 20 soak cycles were used. The scaffolds were characterized by Fourier transform infra red (FTIR) spectroscopy and live/dead staining of the cells that went through the alternating soak cycles. At 10 and 50 mM strength the number of live cells was not statistically reduced, but above these strengths there was a decrease in the number of live cells.
POLYMER DEPOSITION ONTO CERAMICS
Kim et al. [51] coated scaffolds of HA with an HA/PCL composite doped with tetracycline hydrochloride antibiotic for potential use as a drug delivery system. The HA scaffold was dip coated with between 20 and 80 wt% HA in PCL. The compressive stiffness and strength increased from 0.79 ¡ 0.04 to 1.43 ¡ 0.2 MPa and from 0.16 ¡ 0.04 to 0.45 ¡ 0.04 MPa, respectively when the maximum amount of 50 wt% HA coating was applied. Initially the drug release was fast and then slowed, but continued up to 7 days. Abarrategi et al. [52] deposited chitosan onto b-TCP discs. The discs were produced by mixing b-TCP, calcium phosphate, and calcium carbonate (CaCO 3 ) with a solution of acetic acid (CH 3 COOH). Pores were generated by the CaCO 3 -CH 3 COOH interaction which produced CO 2 . Once the discs had set, sterilized, washed in the medium and dried, they were either coated with chitosan-containing recombinant human bone morphogenic protein-2 (rhBMP-2) or allowed to absorb the rhBMP-2 directly into their surfaces. The manufacturing process produced discs that were just over 50 per cent porous and the porosity was reduced to approximately 47 per cent by the chitosan coating although the process did alter the distribution of pore sizes. The production process gradually increased the strength from the 'green' discs to the sterilized and washed discs at 8.30 MPa and after chitosan coating to 11.28 MPa. After cell culture the devices were implanted into 8 mm diameter defects in rabbit skulls. The discs coated in plain chitosan and those with absorbed rhBMP-2 but no chitosan produced a 'good bone response' after 3 weeks, but those coated with chitosan containing rhBMP-2 were totally covered with new bone.
Cao et al. [53] used sol-gel processing to produce porous A-W glass-ceramic porous scaffolds which were then coated with chitosan. This coating increased the strength by a factor of over eight, bringing the strength into the range for cancellous bone, but reduced the bone bioactivity as measured by soaking in SBF; however, osteoblast cell adhesion was still good.
Mantos et al. [54] used a PU model to produce porous scaffolds of 50%SiO 2 -22.6%CaO-5.9%Na 2 O-4%P 2 O 5 -12%K 2 O-5.3%MgO-0.2%B 2 O 3 glass which were subsequently dip coated in PLDLA to produce a 1-5 mm thick layer. The coating covered all the struts of the scaffold and increased the strength from 0.4 to 0.6 MPa. The porosity ranged between 61 and 73 per cent with the average pore size between 250 and 300 mm and soaking in SBF for 3 days lead to the production of an HCA layer on the scaffolds.
CHARACTERIZATION OF THE SCAFFOLDS
Georgiou et al. [55] manufactured scaffolds of PLA reinforced with 46%CaO-4%Na 2 O-50%P 2 O 5 glass, with the porosity produced using supercritical CO 2 . DMA testing showed that the storage modulus of the solid material was increased from 4.4 to 5.2 GPa by the addition of 20 wt% glass. However, the material and material porosity were inhomogeneous at this filler level. The ion release rate depended on the glass content. Culturing of human fetal bone cells showed the material to be biocompatible.
Gelsinsky et al. [56] manufactured porous scaffolds of type-I collagen reinforced by HA and then generated porosity using a freeze drying process. Bradt et al. [57] reported the simultaneous reassembly of the collagen fibrils and precipitation of nanoparticles of HA. After the freeze drying process the scaffolds were cross-linked. The pores produced were approximately 200 mm in diameter and thermogravimetric measurement showed the composite to be approximately 66 wt% HA. FTIR spectroscopy confirmed the presence of type-I collagen and HA and microtomography showed the porosity to be about 72 per cent with a mean pore diameter of 180 ¡ 12 mm. The compressive strength when swollen in water was 14 MPa at 20 per cent strain and 23.5 MPa at 40 per cent strain. After 14 days a culture of viable human marrow stromal cells was found to have infiltrated throughout the scaffold although there was a higher concentration at the edges compared with the centre.
IN VITRO TESTING OF SCAFFOLDS
Haimi et al. [58] cultured human adipose stem cells on PLA reinforced with between 0 and 20 wt% of either b-TCP or a bioactive glass based on 5%Na 2 O-7.5%K 2 O-3%MgO-25%CaO-59.5%SiO 2 with porosity produced by freeze drying. After 2 weeks, compared to non-reinforced PLA scaffolds, more cells were seen on the scaffolds reinforced with b-TCP and fewer cells on the scaffolds reinforced with the bioactive glass. Higher alkaline phosphatase activity was seen on the b-TCP-reinforced scaffolds after both 1 and 2 weeks, with no difference between the non-reinforced PLA scaffold and that reinforced with the bioactive glass.
IN VITRO CELL SEEDING ONTO COMPOSITE SCAFFOLDS
Blaker et al. [59] and Maquet et al. [60] used freeze drying to produce porosity in a composite of PLDLA reinforced with Bioglass 45S5 with a mean particle size of . 5 mm, at either 5 or 40 wt% Bioglass. Cell culture experiments were performed using the human osteosarcoma cell line MG-63. The mean macropore size was 100 mm and the pores were interconnected via micropores of 10-50mm, with scaffold anisotropy. Soaking in 1SBF showed the materials to be bioactive in vitro. Surprisingly, the cell culture resulted in similar numbers of osteoblasts in the scaffolds for scaffolds containing either 5 or 40 wt% Bioglass although in both these cases this was more than on the plain PLDLA scaffolds. Cai et al. [61] used a combination of alginate and gelatine reinforced with TCP to produce scaffolds. They varied the degree of oxidation of the alginate to change the properties but found that neonatal rat calvaria osteoblasts were able to grow on the materials. Furthermore, they showed that the material could be used for drug release.
IN VIVO TESTING OF SCAFFOLDS
Dutta Roy et al. [62] used a three-dimensional printing process to produce scaffolds of two different molecular weight PLGA reinforced with 20 wt% b-TCP with or without internal channels, but all with porosity created using salt crystals. These scaffolds were implanted into the skulls of New Zealand white rabbits for 8 weeks in sub-critical sized defects. Both types of low molecular weight implants collapsed into the defects with minimal new bone formation, however, using the higher molecular weight polymer, the implants survived the implantation with some new bone formation seen in the channels, however, the amount of new bone formed was less than with autograft.
Dawson et al. [63] cultured human-bone-marrow stromal cells on scaffolds of type-1 collagen reinforced with 70 wt% carbonated HA (cHA) produced by Sachlos et al. [64] using a freeze drying process prior to subcutaneous implantation and compared their results with type-I collagen scaffolds without cHA. The mean pore size in the composite scaffolds was 165 mm in the composite scaffold and less than 64 mm in the collagen. These pore sizes were created to produce a biphasic material that would encourage bone ingrowth in the composites and cartilage regeneration in the collagen scaffold thus allowing the repair of osetocondral defects. They found that the composite scaffold supported osteogenesis in vitro although they did have difficulties in differentiating between newly formed collagen and that of the scaffolds. The humanbone-marrow stromal cells penetrated into the scaffolds with high levels of alkaline phosphatase activity. In vivo studies were performed by seeding the collagen HA scaffolds followed by cell culture for 72 h and then implanting subcutaneously for 4 weeks or seeding and culturing for 48 h and then implanting into a defect in the mouse femur. Subcutaneous implantation lead to osteoid formation and good integration was seen with the bony defects.
DISCUSSION
The use of composite production techniques has increased the control of scaffold microstructures and allowed the production of scaffolds with the required combination of 300-400 mm diameter macropores and communicating micropores. The biological activities of these scaffolds have been measured using three major types of tests:
(a) soaking in SBF to see if an hydrated apatite layer is produced which is indicative of the likelihood of a similar process occurring in vivo; (b) cell culture to both ensure that the material produced is not cytotoxic and more importantly to show the bone cells, both primary cell culture and immortalized cell lines, are up regulated again indicating an expected similar beneficial response in vivo; (c) in vivo testing.
Many of the synthesized scaffolds show appropriate levels of porosity and bioactivity, however, they are plagued by poor mechanical properties (Table 1) particularly when compared to the properties of natural cancellous bone [65] . The use of perfusion and similar techniques leads to improved cell distribution. While a range of possible materials have been developed and tested, as yet none of them fulfil all the requirements for a bone tissue engineering scaffold. In general, the mechanical properties of these systems are significantly worse than those of human cancellous bone and they are thus unable to provide even minimal mechanical support. However, many of these materials have been show to be bioactive using tests from soaking in SBF through to in vivo implantation, although their use in critical size defects has not as yet been reported. It seems likely that in the next few years the production of improved bone cell scaffolds will yield a system that possesses both the required biological activity and mechanical strength.
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